Discovery of novel hydroxy-thiazoles as HIF-α prolyl hydroxylase inhibitors:: SAR, synthesis, and modeling evaluation

被引：39

作者：

Tegley, Christopher M. ^{[1
]}

Viswanadhan, Vellarkad N. ^{[1
]}

Biswas, Kaustav ^{[1
]}

Frohn, Michael J. ^{[1
]}

Peterkin, Tanya A. N. ^{[1
]}

Chang, Catherine ^{[1
]}

Burli, Roland W. ^{[1
]}

Dao, Jennifer H. ^{[1
]}

Veith, Henrike ^{[1
]}

Rogers, Norma ^{[1
]}

Yoder, Sean C. ^{[1
]}

Biddlecome, Gloria ^{[1
]}

Tagari, Philip ^{[1
]}

Allen, Jennifer R. ^{[1
]}

Hungate, Randall W. ^{[1
]}

机构：

[1] Amgen Inc, Thousand Oaks, CA 91320 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2008年 / 18卷 / 14期

关键词：

proyl hydroxylase inhibitors; HIF-1; alpha; hypoxia; ischemia; anemia; peripheral arterial disease; myocardial infarction; stroke; diabetes; hydroxy-thiazole;

D O I：

10.1016/j.bmcl.2008.06.031

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Inhibition of the PHD2 enzyme has been associated with increased red blood cell levels. From a screening hit, a series of novel hydroxyl-thiazoles were developed as potent PHD2 inhibitors. (C) 2008 Elsevier Ltd. All rights reserved.

引用

页码：3925 / 3928

页数：4

共 50 条

[1] HIF-α Prolyl Hydroxylase Inhibitors and Their Implications for Biomedicine: A Comprehensive Review
Hirota, Kiichi
[J]. BIOMEDICINES, 2021, 9 (05)
[2] Discovery of novel 2-[2-(3-hydroxy-pyridin-2-yl)-thiazol-4-yl]-acetamide derivatives as HIF prolyl 4-hydroxylase inhibitors; SAR, synthesis and modeling evaluation
Hong, Yong Rae
Kim, Hyun Tae
Ro, Seonggu
Cho, Joong Myung
Lee, Sang Hwi
Kim, In Su
Jung, Young Hoon
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (14) : 3142 - 3145
[3] Novel inhibitors of HIF prolyl hydroxylase and their preclinical characterization
Khristichenko, A.
Smirnova, N.
Andrey, O.
Zakhariants, A.
Gazaryan, I.
Tonevitsky, A.
Poloznikov, A.
[J]. FEBS OPEN BIO, 2018, 8 : 251 - 251
[4] Design and synthesis of a series of novel pyrazolopyridines as HIF 1-α prolyl hydroxylase inhibitors
Warshakoon, Namal C.
Wu, Shengde
Boyer, Angelique
Kawamoto, Richard
Renock, Sean
Xu, Kevin
Pokross, Matthew
Evdokimov, Artem G.
Zhou, Songtao
Winter, Carol
Walter, Richard
Mekel, Marlene
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (21) : 5687 - 5690
[5] Novel dioxygenases, HIF-α specific prolyl-Hydroxylase and asparanginyl-Hydroxylase: O2 switch for Cell survival
Park H.
[J]. Toxicological Research, 2008, 24 (2) : 101 - 107
[6] Structure-based design, synthesis, and SAR evaluation of a new series of 8-hydroxyquinolines as HIF-1α prolyl hydroxylase inhibitors
Warshakoon, Namal C.
Wu, Shengde
Boyer, Angelique
Kawamoto, Richard
Sheville, Justin
Renock, Sean
Xu, Kevin
Pokross, Matthew
Zhou, Songtao
Winter, Carol
Walter, Richard
Mekel, Marlene
Evdokimov, Artem G.
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (21) : 5517 - 5522
[7] A Combination of 3D-QSAR Modeling and Molecular Docking Approach for the Discovery of Potential HIF Prolyl Hydroxylase Inhibitors
Teli, Mahesh Kumar
Krishnamurthy, Rajanikant Golgodu
[J]. MEDICINAL CHEMISTRY, 2013, 9 (03) : 360 - 370
[8] Identification of novel potential HIF-prolyl hydroxylase inhibitors by in silico screening
Teli, Mahesh Kumar
Rajanikant, G. K.
[J]. MOLECULAR DIVERSITY, 2012, 16 (01) : 193 - 202
[9] Identification of novel potential HIF-prolyl hydroxylase inhibitors by in silico screening
Mahesh Kumar Teli
G. K. Rajanikant
[J]. Molecular Diversity, 2012, 16 : 193 - 202
[10] Prolyl hydroxylase inhibitors to active HIF as a novel therapeutic approach against CKD
Nangaku, Masaomi
[J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2008, 106 : 29P - 29P

← 1 2 3 4 5 →